Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HealthTech BioActives (HTBA) is a global leader in the development and manufacturing of high-value active pharmaceutical ingredients (APIs) and functional health ingredients, specializing in citrus-derived flavonoids and Vitamin B12 derivatives. The company's flagship brand, MecobalActive, is a high-purity methylcobalamin produced through a sustainable, ecologically friendly chemical synthesis process that avoids the use of toxic solvents. HTBA serves the pharmaceutical, nutraceutical, and food and beverage industries, providing ingredients that support cardiovascular, metabolic, and neurological health. Originally a division of the Spanish pharmaceutical group Ferrer, HTBA was acquired by The Riverside Company in 2019 to operate as an independent global platform. The company maintains state-of-the-art manufacturing facilities in Spain and focuses on delivering science-based solutions for the global health market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MecobalActive.